Our in vitro data suggested that the dampened T cell responses seen in mice bearing p53KO tumors may be a consequence of pro-tumorigenic myeloid cells responding to elevated M-CSF from p53-ablated cancer cells (Figure 2G). The gene discussed is TP53; the disease is cancer.